BMP3 ELISA Kits Search Results


mk101  (TaKaRa)
96
TaKaRa mk101
Mk101, supplied by TaKaRa, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mk101/product/TaKaRa
Average 96 stars, based on 1 article reviews
mk101 - by Bioz Stars, 2026-04
96/100 stars
  Buy from Supplier
bmp3  (Novus Biologicals)
91
Novus Biologicals bmp3
The decrease of BMP circulating concentration and the deficiency of BMP/Smad signaling in IDD patients. (A-F) Serum concentrations of BMPs. Circulating levels of BMP1 (A) , BMP2 (B) , <t>BMP3</t> (C) , BMP4 (D) , BMP5 (E) , and BMP7 (F) were measured in serum samples obtained from healthy controls ( n = 20) and IDD patients ( n = 20). * P < 0.05 and ** P < 0.01. (G) The protein levels of BMP/Smad signaling molecules. Total cell extracts from the IVDs in one control and different Pfirrmann grades (I-IV) were subjected to immunoblots to examine the protein levels of BMPR1a, BMPR1b, BMPR2, Smad1/5/8, pSSmad1/5/8, Smad4, and β-Actin (loading control).
Bmp3, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bmp3/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
bmp3 - by Bioz Stars, 2026-04
91/100 stars
  Buy from Supplier
elisa kit bmp3  (MyBiosource Biotechnology)
90
MyBiosource Biotechnology elisa kit bmp3
The decrease of BMP circulating concentration and the deficiency of BMP/Smad signaling in IDD patients. (A-F) Serum concentrations of BMPs. Circulating levels of BMP1 (A) , BMP2 (B) , <t>BMP3</t> (C) , BMP4 (D) , BMP5 (E) , and BMP7 (F) were measured in serum samples obtained from healthy controls ( n = 20) and IDD patients ( n = 20). * P < 0.05 and ** P < 0.01. (G) The protein levels of BMP/Smad signaling molecules. Total cell extracts from the IVDs in one control and different Pfirrmann grades (I-IV) were subjected to immunoblots to examine the protein levels of BMPR1a, BMPR1b, BMPR2, Smad1/5/8, pSSmad1/5/8, Smad4, and β-Actin (loading control).
Elisa Kit Bmp3, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kit bmp3/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
elisa kit bmp3 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
fgf-2, jag-1, bmp3, wnt-5a, and wnt10b elisas  (Antibodies-Online Inc)
90
Antibodies-Online Inc fgf-2, jag-1, bmp3, wnt-5a, and wnt10b elisas
The decrease of BMP circulating concentration and the deficiency of BMP/Smad signaling in IDD patients. (A-F) Serum concentrations of BMPs. Circulating levels of BMP1 (A) , BMP2 (B) , <t>BMP3</t> (C) , BMP4 (D) , BMP5 (E) , and BMP7 (F) were measured in serum samples obtained from healthy controls ( n = 20) and IDD patients ( n = 20). * P < 0.05 and ** P < 0.01. (G) The protein levels of BMP/Smad signaling molecules. Total cell extracts from the IVDs in one control and different Pfirrmann grades (I-IV) were subjected to immunoblots to examine the protein levels of BMPR1a, BMPR1b, BMPR2, Smad1/5/8, pSSmad1/5/8, Smad4, and β-Actin (loading control).
Fgf 2, Jag 1, Bmp3, Wnt 5a, And Wnt10b Elisas, supplied by Antibodies-Online Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fgf-2, jag-1, bmp3, wnt-5a, and wnt10b elisas/product/Antibodies-Online Inc
Average 90 stars, based on 1 article reviews
fgf-2, jag-1, bmp3, wnt-5a, and wnt10b elisas - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
elisa kits  (MyBiosource Biotechnology)
90
MyBiosource Biotechnology elisa kits
rhBMP3 inhibits VC in vitro and is elevated in the circulation of GDF1 0 −/− mice with VC. A , HA crystal formation in wild-type (C57BL/6J) mouse VSMCs (n = 5-10) following P i (2.6 mM) treatment for 5 days in the presence or absence of rhGDF10 (100-200 ng/ml; n = 8) or BMP3 (100-200 ng/ml; n = 8). B , Quantification of alkaline phosphatase activity in wild-type VSMCs following 4 days of P i (2.6 mM) and rhGDF10 rhGDF10 (100-200 ng/ml; n = 8) or BMP3 (100-200 ng/ml; n = 8). C , circulating BMP3 levels <t>in</t> <t>GDF10</t> +/+ or GDF10 −/− (n = 6) as measured by <t>ELISA.</t> All data are shown as mean and error bars as SD. ∗, p < 0.01, vs. Vehicle; &, p < 0.01/0/05, vs. P i /GDF10 +/+ VD 3 , by 1-way ANOVA with Tukey multiple comparison testing using Prism 6 (GraphPad) as indicated in the figure for each applicable figure panel.
Elisa Kits, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/elisa kits/product/MyBiosource Biotechnology
Average 90 stars, based on 1 article reviews
elisa kits - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier
bmp15  (Cusabio)
93
Cusabio bmp15
rhBMP3 inhibits VC in vitro and is elevated in the circulation of GDF1 0 −/− mice with VC. A , HA crystal formation in wild-type (C57BL/6J) mouse VSMCs (n = 5-10) following P i (2.6 mM) treatment for 5 days in the presence or absence of rhGDF10 (100-200 ng/ml; n = 8) or BMP3 (100-200 ng/ml; n = 8). B , Quantification of alkaline phosphatase activity in wild-type VSMCs following 4 days of P i (2.6 mM) and rhGDF10 rhGDF10 (100-200 ng/ml; n = 8) or BMP3 (100-200 ng/ml; n = 8). C , circulating BMP3 levels <t>in</t> <t>GDF10</t> +/+ or GDF10 −/− (n = 6) as measured by <t>ELISA.</t> All data are shown as mean and error bars as SD. ∗, p < 0.01, vs. Vehicle; &, p < 0.01/0/05, vs. P i /GDF10 +/+ VD 3 , by 1-way ANOVA with Tukey multiple comparison testing using Prism 6 (GraphPad) as indicated in the figure for each applicable figure panel.
Bmp15, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bmp15/product/Cusabio
Average 93 stars, based on 1 article reviews
bmp15 - by Bioz Stars, 2026-04
93/100 stars
  Buy from Supplier
elisa kit bmp 3 human  (G Biosciences)
N/A
An ELISA kit for the detection of BMP 3 Human This uses Sandwich ELISA Double Antibody and has a sensitivity of 0 094ng ml
   Buy from Supplier
human bone morphogenetic protein 3 (bmp3) elisa kit  (Bioss)
N/A
   Buy from Supplier
rat bmp-3 elisa kit (colorimetric)  (Novus Biologicals)
N/A
Rat BMP-3 ELISA Kit (Colorimetric)
   Buy from Supplier
human bone morphogenetic protein 3(bmp3) elisa kit  (Cusabio)
N/A
Human Bone morphogenetic protein 3(BMP3) ELISA kit
   Buy from Supplier
elisa kit bmp 3 rat  (G Biosciences)
N/A
An ELISA kit for the detection of BMP 3 Rat This uses Sandwich ELISA Double Antibody and has a sensitivity of 37 5pg ml
   Buy from Supplier

Image Search Results


The decrease of BMP circulating concentration and the deficiency of BMP/Smad signaling in IDD patients. (A-F) Serum concentrations of BMPs. Circulating levels of BMP1 (A) , BMP2 (B) , BMP3 (C) , BMP4 (D) , BMP5 (E) , and BMP7 (F) were measured in serum samples obtained from healthy controls ( n = 20) and IDD patients ( n = 20). * P < 0.05 and ** P < 0.01. (G) The protein levels of BMP/Smad signaling molecules. Total cell extracts from the IVDs in one control and different Pfirrmann grades (I-IV) were subjected to immunoblots to examine the protein levels of BMPR1a, BMPR1b, BMPR2, Smad1/5/8, pSSmad1/5/8, Smad4, and β-Actin (loading control).

Journal: International Journal of Biological Sciences

Article Title: Recombinant human bone morphogenetic protein 2 and 7 inhibit the degeneration of intervertebral discs by blocking the Puma-dependent apoptotic signaling

doi: 10.7150/ijbs.56823

Figure Lengend Snippet: The decrease of BMP circulating concentration and the deficiency of BMP/Smad signaling in IDD patients. (A-F) Serum concentrations of BMPs. Circulating levels of BMP1 (A) , BMP2 (B) , BMP3 (C) , BMP4 (D) , BMP5 (E) , and BMP7 (F) were measured in serum samples obtained from healthy controls ( n = 20) and IDD patients ( n = 20). * P < 0.05 and ** P < 0.01. (G) The protein levels of BMP/Smad signaling molecules. Total cell extracts from the IVDs in one control and different Pfirrmann grades (I-IV) were subjected to immunoblots to examine the protein levels of BMPR1a, BMPR1b, BMPR2, Smad1/5/8, pSSmad1/5/8, Smad4, and β-Actin (loading control).

Article Snippet: ELISA assays were performed to determine the circulating concentrations of BMPs using their individual kits, including BMP1 (Novus Biologicals, Centennial, CO, USA; #NBP2-69978), BMP2 (Abcam, Shanghai, China; #ab119581), BMP3 (Novus Biologicals; #NBP2-69993), BMP4 (Abcam; #ab231930), BMP5 (Abcam; #ab119583), BMP6 (Thermo Fisher; #EHBMP6), BMP7 (Abcam; #ab99985), BMP8A (CUSABIO, Wuhan, Hubei, China; #Q7Z5Y6), BMP8B (CUSABIO; #P34820), BMP10 (CUSABIO; #Q95393), and BMP15 (CUSABIO; #Q95972).

Techniques: Concentration Assay, Control, Western Blot

rhBMP3 inhibits VC in vitro and is elevated in the circulation of GDF1 0 −/− mice with VC. A , HA crystal formation in wild-type (C57BL/6J) mouse VSMCs (n = 5-10) following P i (2.6 mM) treatment for 5 days in the presence or absence of rhGDF10 (100-200 ng/ml; n = 8) or BMP3 (100-200 ng/ml; n = 8). B , Quantification of alkaline phosphatase activity in wild-type VSMCs following 4 days of P i (2.6 mM) and rhGDF10 rhGDF10 (100-200 ng/ml; n = 8) or BMP3 (100-200 ng/ml; n = 8). C , circulating BMP3 levels in GDF10 +/+ or GDF10 −/− (n = 6) as measured by ELISA. All data are shown as mean and error bars as SD. ∗, p < 0.01, vs. Vehicle; &, p < 0.01/0/05, vs. P i /GDF10 +/+ VD 3 , by 1-way ANOVA with Tukey multiple comparison testing using Prism 6 (GraphPad) as indicated in the figure for each applicable figure panel.

Journal: The Journal of Biological Chemistry

Article Title: GDF10 is a negative regulator of vascular calcification

doi: 10.1016/j.jbc.2024.107805

Figure Lengend Snippet: rhBMP3 inhibits VC in vitro and is elevated in the circulation of GDF1 0 −/− mice with VC. A , HA crystal formation in wild-type (C57BL/6J) mouse VSMCs (n = 5-10) following P i (2.6 mM) treatment for 5 days in the presence or absence of rhGDF10 (100-200 ng/ml; n = 8) or BMP3 (100-200 ng/ml; n = 8). B , Quantification of alkaline phosphatase activity in wild-type VSMCs following 4 days of P i (2.6 mM) and rhGDF10 rhGDF10 (100-200 ng/ml; n = 8) or BMP3 (100-200 ng/ml; n = 8). C , circulating BMP3 levels in GDF10 +/+ or GDF10 −/− (n = 6) as measured by ELISA. All data are shown as mean and error bars as SD. ∗, p < 0.01, vs. Vehicle; &, p < 0.01/0/05, vs. P i /GDF10 +/+ VD 3 , by 1-way ANOVA with Tukey multiple comparison testing using Prism 6 (GraphPad) as indicated in the figure for each applicable figure panel.

Article Snippet: Commercially available ELISA kits were used to measure serum levels of mouse GDF10 (Elabscience) and BMP3 (MyBioSource) according to the manufacturer’s instructions.

Techniques: In Vitro, Activity Assay, Enzyme-linked Immunosorbent Assay, Comparison